Adaptive Biotechnologies (ADPT) Interest & Investment Income (2018 - 2026)

Adaptive Biotechnologies has reported Interest & Investment Income for 9 years, with the latest figure at $2.1 million in Q1 2026.

• Quarterly Interest & Investment Income fell 22.36% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 31.91% YoY) and the FY2025 annual result came in at $9.4 million, down 35.02% from the prior year.
• Interest & Investment Income eased to $2.1 million in Q1 2026 per ADPT's latest filing, from $2.1 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $4.6 million in Q4 2023 and troughed at $271000.0 in Q1 2022.
• A 5-year average of $2.7 million and a median of $2.7 million in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2022 and 2023: Interest & Investment Income tumbled 57.52% in 2022, then surged 1015.87% in 2023.
• Over 5 years, Interest & Investment Income stood at $2.6 million in 2022, then jumped by 77.29% to $4.6 million in 2023, then slumped by 33.41% to $3.1 million in 2024, then tumbled by 30.08% to $2.1 million in 2025, then retreated by 3.17% to $2.1 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $2.1 million, $2.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.